| Date Filed | Type | Description |
| 08/24/2023 |
4
| Taitel Haya (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Bought 18,000 shares
@ $0.6231, valued at
$11.2k
|
|
| 08/24/2023 |
3
| Taitel Haya (Director) has filed a Form 3 on Entera Bio Ltd. |
| 08/23/2023 |
4
| LIEBERMAN GERALD M (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Bought 20,000 shares
@ $0.5892, valued at
$11.8k
|
|
| 08/22/2023 |
4
| Ellis Sean (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Bought 40,000 shares
@ $0.6, valued at
$24k
|
|
| 08/15/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/11/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 07/28/2023 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials: |
| 06/30/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 06/29/2023 |
25-NSE/A
| Form 25-NSE/A - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: [Amend] |
| 06/07/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/05/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
8-K
| Quarterly results |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2023 |
4
| Toledano Miranda Jayne (CEO) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Bought 30,000 shares
@ $1.01, valued at
$30.3k
|
|
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/31/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 1% stake in Entera Bio Ltd. |
| 01/04/2023 |
4
| GARCEAU ROGER (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Granted 89,041 options to buy
@ $0.73, valued at
$65k
|
|
| 01/04/2023 |
4
| LIEBERMAN GERALD M (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Granted 89,041 options to buy
@ $0.73, valued at
$65k
|
|
| 01/04/2023 |
4
| Mayron Ron (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Granted 89,041 options to buy
@ $0.73, valued at
$65k
|
|
| 01/04/2023 |
4
| OSTROV GERALD M (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Granted 89,041 options to buy
@ $0.73, valued at
$65k
|
|
| 01/04/2023 |
4
| Malca Yonatan (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Granted 89,041 options to buy
@ $0.73, valued at
$65k
|
|
| 01/04/2023 |
4
| Ellis Sean (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Granted 89,041 options to buy
@ $0.73, valued at
$65k
|
|
| 11/23/2022 |
8-K
| Quarterly results |
| 11/18/2022 |
SC 13G/A
| CENTILLION FUND INC. reports a 8.3% stake in ENTERA BIO LTD. |
| 11/17/2022 |
SC 13G/A
| CENTILLION FUND INC. reports a 4.4% stake in ENTERA BIO LTD. |
| 11/17/2022 |
SC 13G/A
| CENTILLION FUND INC. reports a 4.4% stake in ENTERA BIO LTD. |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Ellis Sean (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Bought 30,000 shares
@ $0.53, valued at
$15.9k
|
|
| 11/14/2022 |
4
| Toledano Miranda Jayne (CEO) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Bought 50,000 shares
@ $0.5317, valued at
$26.6k
|
|
|